Sensors inspired by nature

The quest to mimic the exquisite flow sensing of marine animals paved the way to the Rely-V technology!

Sencilia is trusted by

Discover Sencilia: Transforming MedTech!

Sencilia, an early-stage MedTech startup, is a spin-off from the Bioinspired MEMS and Biomedical Devices (BMBD) group at the University of Groningen. Dr. Amar M. Kamat (former postdoc in BMBD and currently the CEO of Sencilia) and Prof. Ajay G.P. Kottapalli (Associate Professor and Chair of the BMBD group) founded Sencilia in Sep 2021 in order to utilize and valorize the extensive knowhow in sensor technology and nanofabrication generated within the BMBD group over many years.

Sencilia aims to enhance the safety of IV infusion therapy, and harbors the vision of becoming the standard of care in IV drug administration by 2030.

Currently at a design/development stage (TRL = 4), we're partnering with world-renowned hospitals such as Erasmus MC and UMCG to co-develop our product, and are aiming for a market launch in 2026. Join us on this exciting journey as we revolutionize IV infusion monitoring technology!

Introducing Rely-V

Rely-V is an innovative IV flow monitoring technology designed for clinicians, offering real-time dosage insights for neonatal and pediatric patients

Core Team

Amar oversees the technology and business development activities at Sencilia

Dr. Amar M. Kamat, PhD

Founder and CEO

Natanael leads the R&D efforts in hardware/software development

Ir. Natanael Gomes, MSc


Felix leads the R&D efforts in sensor design and data analysis

Ir. Felix Wood, MSc


Ajay acts as the chief advisor on micro and nano fabrication

Prof. Dr. Ajay G.P. Kottapalli, PhD

Scientific Founder and Technology Advisor

Associate Professor and Chair of BMBD group, University of Groningen

Leon acts as the chief advisor on business development and strategic partnerships

Dr. Leon Ramselaar, PhD MBA

Business Advisor and Strategic Partnerships Lead

Thom specializes in design, prototyping, testing and fabrication

Ir. Thom van der Honing, BSc

Biomedical Design Engineer

Mona specializes in the design of electronics

Ir. Mona Kargar, MSc

Electronics Engineer​


Prof. Dr. Michael Triantafyllou

Scientific Advisor

Professor of Mechanical and Ocean Engineering, Massachusetts Institute of Technology (MIT), USA

Prof. Dr. Bayu Jayawardhana

Scientific Advisor

Professor in Mechatronics and Control of Nonlinear Systems, University of Groningen

Dr. Maarten Nijsten (MD PhD)

Clinical Advisor

Intensivist (Complex Cardio), UMCG

Dr. Anna-Linda Peters (MD PhD)

Clinical Advisor

Anesthesiologist and Intensive Care Fellow, UMC Amsterdam

Roland van Rens, MA

Clinical (Nursing) Advisor

Senior NICU nurse and PhD candidate, Radboud University

Dr. Bart Nelissen

MedTech coach accelerator venture acceleration manager

Stéfan Ellenbroek

MedTech coach

unlock_ incubator program director

Any questions? Let's talk!

We are open to partnerships

Sencilia Timeline



NWO Take off 1 grant (€40k) awarded to explore the feasibility of IV infusion monitoring using bioinspired sensors



NWO Take off 1 project completed successfully, technical and commercial feasibility proven


Incorporation of Sencilia with pre-seed investment from RUG Ventures and Triade, the venture arms of the University of Groningen and UMCG
Natanael Gomes and Felix Wood join Sencilia as R&D Engineers



Leon Ramselaar joins Sencilia as a business mentor and strategic partnerships lead


Sencilia is awarded the 5G subsidy (€50k) from SNN and 5Groningen


Demonstrator video of early occlusion detection sensor ready


Sencilia is selected to join, a world-leading accelerator program for tech startups



Sencilia wins first place in the Draper Spring Pitch competition organized by LUMO Labs and Draper University, with a €14k award to Amar Kamat to attend the Hero Training program by Draper University in Silicon Valley
Sencilia is scouted and selected to join Medlim, a MedTech accelerator program organized by Medtronic (11 MedTech startups were selected from all over Europe, acceptance rate of 12%)


Sencilia successfully completes the Venture Challenge program organized by life sciences@work, NWO and Health Holland

The SmartInfuus project (led by Sencilia in collaboration with the UMCG and University of Groningen) is awarded the SNN Valorisatie 2022 subsidy (€321k) by the European Regional Development Funds (ERDF) to perform preclinical validation of its technology


Sencilia is awarded the NWO Take-off 2 subsidy (€250k) as early-stage financing (vroegfasefinanciering) to continue its technology and business development


Sencilia wins a pilot project with the Erasmus MC as part of the Health Care and Tech program organized by YES!Delft and Erasmus MC
Sencilia signs an intellectual property license agreement with the University of Groningen


Sencilia is selected as one of the winners of the Academic Startup Competition 2024 organized by TeachLeapNL



Thom van der Honing and Mona Kargar hired as Design Engineers

Safer IV infusions